Hypoxia-inducible factors and diabetes

Area of Science:

• Physiology
• Endocrinology
• Molecular Biology

Background:

• Hypoxia, a state of oxygen deficiency, is regulated by Hypoxia-Inducible Factors (HIFs).
• HIFs are implicated in the pathogenesis and complications of diabetes, influencing both microvascular and macrovascular health.
• Hyperglycemia, common in diabetes, destabilizes HIF-1α protein, complicating its role.

Purpose of the Study:

• To review the multifaceted role of HIFs in diabetes.
• To discuss evidence linking HIFs to beta cell dysfunction, diabetes development, and complications.
• To examine the variable outcomes of HIF-targeting strategies in diabetes.

Main Methods:

• Literature review of studies on hypoxia, HIF biology, and diabetes.
• Analysis of evidence implicating HIFs in diabetes pathogenesis and complications.
• Examination of clinical and preclinical data on HIF-targeting approaches.

Main Results:

• HIFs are critical regulators of cellular response to hypoxia, with complex interactions in diabetes.
• Improving glucose control in diabetes can increase HIF-1α, yielding some benefits.
• Current strategies targeting HIF-1α for diabetes treatment have shown limited clinical success.
• Discrepant effects of HIF-1α modulation observed across different tissues and conditions.

Conclusions:

• The interplay between HIF biology and diabetes is intricate and not fully understood.
• Further research is needed to clarify the precise roles of HIFs and develop effective therapeutic strategies.
• Targeting HIFs in diabetes presents challenges due to context-dependent and sometimes contradictory effects.